Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

National Cerebral and Cardiovascular Center (NCVC) Stroke Registry

Trial Profile

National Cerebral and Cardiovascular Center (NCVC) Stroke Registry

Not stated
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 21 Sep 2018

At a glance

  • Drugs Apixaban (Primary) ; Rivaroxaban (Primary)
  • Indications Stroke; Transient ischaemic attacks
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Sep 2018 New trial record
    • 11 Sep 2018 Results published in the Circulation Journal
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top